Skip to content
Clinical Trials – home

Marien Hospital Herne Universitätsklinikum der Ruhr-Universität Bochum

Verifiedinfo

Germany Hoelkeskampring 40, 44625 Herne, Germany

  • 7 trials recruiting
  • Chronic lymphocytic leukaemia · Prostate cancer metastatic · Acute myeloid leukaemia
  • Adult patients

About Specializations

Marien Hospital Herne Universitätsklinikum der Ruhr-Universität Bochum in Herne, Germany specialises in clinical trials of conditions such as Chronic lymphocytic leukaemia, Prostate cancer metastatic, Acute myeloid leukaemia, Bladder cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, with a particular focus on Muscle Invasive Bladder Cancer (MIBC). The institution is dedicated to advancing treatment options and improving patient outcomes through innovative clinical trials.

  • Perioperative therapies
  • Immunotherapy advancements
  • Comparative effectiveness of treatment regimens

By exploring the efficacy of novel combinations such as pembrolizumab and enfortumab vedotin against traditional chemotherapy, the center contributes significantly to the evolving landscape of cancer treatment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hoelkeskampring 4044625 HerneGermany
Recruiting now
7 trials
Conditions studied
34
Partner status
Verified

More sites in HerneGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

28 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Exelixis Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Erdafitinib
  • Sponsor:Janssen Cilag International
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Aciclovir
  • Sponsor:Friedrich-Schiller-Universitaet Jena
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Krankenhaus Nordwest GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Atrial fibrillation

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Universitaetsspital Basel
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BMS-986365
  • Sponsor:AIO-Studien gGmbH

Chronic kidney disease+1

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.